Africa-Press – Botswana. The African Centers for Disease Control and Prevention (Africa CDC) is in the final stages of negotiations for the continent to receive vaccines to prevent the Monkeypox virus, the African Union (AU) agency announced tuesday.
“The negotiations are with partners who have a reserve and we are negotiating access to that reserve so that we can use the vaccines on the continent,” said Ahmed Ogwell, acting director of Africa CDC, in a virtual press conference.
Ogwell clarified that the agreement is not to “buy” the drugs, but to gain access to the stored doses. However, he did not reveal who the partner is or how many units he expects to receive, pending the end of the talks.
“We hope to conclude the negotiations in the next few days. We need to immediately distribute between 80,000 and 100,000 doses,” he added.
Developed countries, such as the United States of America (USA) and members of the European Union (EU), have been acquiring the vaccines so far recommended to immunize against the also known as monkeypox, which has been declared an international health emergency, in July, by the World Health Organization (WHO). These include the Imnavex vaccine, authorized by the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) – where it is marketed under the name Jynneos – against smallpox and Monkeypox. There is also the FDA-approved Acam2000 vaccine against smallpox.
For More News And Analysis About Botswana Follow Africa-Press
